Page last updated: 2024-11-02

piracetam and Craniofacial Pain Syndromes

piracetam has been researched along with Craniofacial Pain Syndromes in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research Excerpts

ExcerptRelevanceReference
"Levetiracetam is an antiepileptic drug with analgesic efficacy shown in pain models and small clinical trials."1.42The effects of levetiracetam, sumatriptan, and caffeine in a rat model of trigeminal pain: interactions in 2-component combinations. ( Micov, AM; Pecikoza, UB; Popović, BV; Stepanović-Petrović, RM; Tomić, MA, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tomić, MA1
Pecikoza, UB1
Micov, AM1
Popović, BV1
Stepanović-Petrović, RM1

Other Studies

1 other study available for piracetam and Craniofacial Pain Syndromes

ArticleYear
The effects of levetiracetam, sumatriptan, and caffeine in a rat model of trigeminal pain: interactions in 2-component combinations.
    Anesthesia and analgesia, 2015, Volume: 120, Issue:6

    Topics: Analgesics; Animals; Behavior, Animal; Caffeine; Disease Models, Animal; Dose-Response Relationship,

2015